Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included pharmaceutical executives appearing before a Senate drug pricing hearing; HHS finalizing a Title X rule change; and an analysis that found travel and wait times for healthcare services come with a high price.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Senate Committee Discusses the Burden of High Drug Prices and Potential Solutions
Pharma Executives Call for Reforms to Medicare, Rebate System in Senate Hearing
HHS Rule Bars Clinics That Perform Abortion, Make Referrals From Receiving Title X Funds
HPV Vaccines Cut Cervical Cancer Rates, Study Shows
Travel, Wait Times for Healthcare Services Cost $89 Billion Annually
American Academy of Allergy, Asthma and Immunology 2019
Read more about the stories in this podcast:
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen